Letters to the Editor: Naperville should not be locked into another IMEA contract
City Councilman Josh McBroom makes the point that the MDR (Member Directed Resource) will enable us to partly outsource our electricity to clean energy sources. This is misleading, at best.
We cannot use an MDR to shave 10% off our peak load without shaving IMEA's demand as a whole. IMEA members will still be required to purchase their full requirements from IMEA. Naperville could use additional money to develop new energy sources and would be paid the 'market price' for those sources, but that might be less than the actual cost to Naperville.
Renewing the contract will obligate Naperville to obtain the same amount of electricity from coal-fired energy plants. We must work to source our electricity from clean energy providers and not commit to continue to support coal burning for another 25 years!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
A self-made millionaire says he doesn't believe in index funds — and explains why he doesn't see options as higher risk
Jason Brown rebuilt his wealth through options trading after early investment losses. Brown's skepticism of traditional investing led him to focus on self-directed options. He emphasizes understanding options to mitigate risk and protect financial assets. Jason Brown built wealth his own way. After a disappointing early experience handing over his money to professionals — he took $2,000 worth of high school graduation money to the bank to invest and, two years later, his account had dropped to $700 — he decided if he was going to lose money, at least it would be on his own terms. As a college student, he started buying stocks and grew his modest savings to six figures before losing it all on one trade. After selling his car, moving back home, and taking a job at Verizon selling cellphones, he started trading again — this time, with a set of investing principles that would prevent him from going broke again. Brown, 43, gradually rebuilt his portfolio and hit the seven-figure mark by trading options. Business Insider confirmed his net worth by reviewing an account summary that shows his 2024 investment activity. An option is a type of financial contract giving you the right, but not the obligation, to buy or sell an asset at a specific price before a specific date. Options are generally more complex than traditional investing, such as buying and holding stocks or index funds, but Brown's adamant that traditional investing doesn't cut it. "I don't really believe in index funds," he told BI. He became skeptical after digging into his 401(k) plan when he worked for Verizon. Specifically, he looked at the fund his 401(k) money was invested in. It was comprised of about five major companies like Apple and Google that he knew and trusted, but "the rest of it was junk," he said. "That's when I was like, I want to move it over to a self-directed IRA, and I just want to pick these five companies. Why are they forcing me to buy all this other stuff?" Index fund investing has helped many regular investors build wealth, but for Brown, who prefers to be more hands-on with his investments, options trading made more sense. 'Options are not risky. The way people use them is risky.' Brown, who trades full-time, runs a financial education company, and is the author of "Five-Year Millionaire," believes there is a lot of misunderstanding around options trading. "When people don't understand options, they'll say, 'That's risky what he's doing.' The reality is, it's risky not knowing how to use options," he said. Stock options can be compared to renters' or car insurance, depending on whether you're buying or selling options and whether you're using calls or puts. For example, buying a put is like buying car insurance. You pay a premium (the cost of the put), and hope nothing bad happens (the stock doesn't crash), but if it does, you're protected: You can sell the stock at the agreed-upon price (the strike price), just like insurance would reimburse you if your car gets totaled. "If options are so risky, then stop paying your homeowner's insurance or your car insurance, because that's what you're doing every month when you cut a check: You are buying a put option to protect yourself in case something happens," said Brown. "Why don't we buy protection for our investment accounts when a COVID-19 happens, when an '08 real estate market crash happens, when a tariffs situation happens, and the market tanks?" Options can require careful timing and market-watching, and Brown knows he won't make money on every trade. "You cannot be right on every trade," he said, which is why he has a robust emergency fund, multiple revenue streams, and follows investing principles, including: Know your "I'm wrong level." When he lost everything in his early 20s, he never considered his "I'm wrong level," he explained. "I only thought, 'What would happen if this goes right? I'm getting a condo.' I never stopped to think, 'If I'm wrong, I'll lose it all and I have to move back home.'" Now, he knows exactly when he needs to cut his losses and shut down a trade. "Options are not risky. The way people use them is risky," said Brown. "You can use them to gamble and treat it like a casino, or you can use them to protect some of your most valuable assets — protect your accounts and grow your accounts." Read the original article on Business Insider
Yahoo
2 days ago
- Yahoo
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif., July 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva Medtech Regulatory Affairs Benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations. Many organizations are manually reconciling data to ensure regulatory compliance, increasing the administrative burden for regulatory affairs teams. With the rise of new technology to streamline and automate regulatory processes, high data quality is paramount for medtech innovation. When considering effective AI implementation, only 17% rate their regulatory data quality as excellent, with the remainder categorizing it as average or worse. The report from Veeva MedTech examines the current state of regulatory operations, including: Lengthy timelines for submission preparation. From data gathering to internal approval, preparing a submission for a 510(k) takes a month or longer for 80% of respondents, with 24% indicating that it takes more than six months. With organizations spending up to two years on each MDR submission, medtechs that reduce submission timelines can get products to market faster with considerable cost and resource savings. Prioritizing time to market measurement. Only 5% of those surveyed use a fully automated process to monitor time to market, a key metric for effective resource planning. About two-thirds (67%) partially or entirely rely on manual processes, making it difficult to generate accurate and timely performance insights. Room for regulatory operational improvement. Respondents identified heavy administrative burden (61%), siloed processes (49%), digital tool proficiency (35%), and educational shortcomings (24%) as the largest gaps in regulatory affairs, all of which may hinder product registrations and slow time to market. Technology advancing regulatory affairs. More organizations are making strategic decisions to improve efficiency and compliance, with 56% planning to adopt a regulatory information management (RIM) system. Nearly half of respondents are looking to develop integrations between existing systems (52%) or implement automated submission tracking and reporting tools (48%) to gain unified, accessible data. "The report illustrates key areas to evolve regulatory affairs to a strategic enabler of business objectives through connected, automated processes for increased data reliability and speed," says Seth Goldenberg, president, Veeva MedTech. "As teams are asked to do more with the same resources, addressing operational gaps to foster agility while maintaining compliance in the evolving regulatory landscape will be critical." The 2025 Medtech Regulatory Affairs Benchmark surveyed a diverse group of 130 regulatory professionals, exploring the most critical challenges facing regulatory teams today. To learn more, read the full benchmark report here. About Veeva MedTech Veeva MedTech helps medical device and diagnostics companies streamline the complete product development and commercialization lifecycles to deliver products to patients with greater speed and efficiency. Veeva MedTech's offering includes applications that advance clinical, regulatory, quality, commercial, and medical operations. For more information, visit About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit Veeva Forward-Looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 32 and 33), and in our subsequent SEC filings, which you can access at Contact:Deivis MercadoVeeva View original content to download multimedia: SOURCE Veeva Systems Error in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
23-07-2025
- Yahoo
Garner by IHG signs new franchise agreement in India
IHG Hotels & Resorts has expanded its footprint in India with a new franchise agreement for Garner Kutch in the state of Gujarat. This marks the third signing under the Garner brand in India since its IMEA launch, with the hotel expected to open in the first quarter of 2026. Garner Kutch will be part of IHG's strategy to grow its portfolio in India's emerging markets, responding to the increasing demand for quality accommodations. A part of IHG's midscale offerings, the new Garner brand is tailored for value-conscious travellers seeking comfort, reliability and convenience. The brand's focus is on relaxed service, flexible spaces, and creating a local experience for guests. Located in Gujarat's largest district, Garner Kutch is set to meet the growing need for trusted midscale hotels in India, particularly through franchising. The property will be operated by Royal Buildspace and managed by Rosastays, a preferred IHG operator for the Garner brand in India. This partnership will also extend to managing Garner Etawah and Garner Kathua, with openings planned for 2026 and 2027. The hotel will feature 40 rooms, an all-day dining restaurant, swimming pool, fitness centre, spa, and meeting and social spaces, catering to a mix of business and leisure travellers. IHG South West Asia managing director Sudeep Jain said: 'The rapid uptake of Garner in India—with three signings in quick succession—demonstrates strong owner confidence in our midscale conversion proposition. Kutch's dynamic growth trajectory aligns perfectly with Garner's ability to deliver asset-light, high-return opportunities for partners like Royal Buildspace. "Together with Rosastays, we're unlocking India's underserved markets, where demand for trusted brands is accelerating.' Kutch's regional development, including the nearby DP World Special Economic Zone, is expected to drive demand for quality accommodations, making the signing of Garner Kutch timely. IHG currently operates 50 hotels across India and has a pipeline of 63 hotels set to open in the next three to five years. "Garner by IHG signs new franchise agreement in India" was originally created and published by Hotel Management Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
